GKOS · Glaukos Corp
United States · RS rating 98 · As of 2026-11-03
| Price | 233.04 USD |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 97 / 93 / 97 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 69 / 79 / 43 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -728.6% |
| Sales growth Q/Q | +7.2% |
| Distance from 52-week high | +3.9% |
| Market cap (USD) | $7.1B |